YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial

1 month ago 27

Nature Medicine - As presented at the European Society for Medical Oncology Congress 2025: In patients with locally advanced or metastatic solid tumours, including mesothelioma, treatment with a...

1. Homepage
2. Cancer Cures
3. YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial